US2022016150A1PendingUtilityA1
Sustained release of antiinfectives
Est. expiryOct 29, 2022(expired)· nominal 20-yr term from priority
A61K 31/545A61K 9/0078Y10S977/773A61K 9/48A61K 31/496A61K 31/7036Y10S977/907A61P 31/00Y10S977/906A61K 9/127Y02A50/30A61K 9/0073A61K 31/407
78
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Provided, among other things, is a method of treating or ameliorating pulmonary infection in a cystic fibrosis patient comprising pulmonary administration of an effective amount of a liposomal/complexed antiinfective to the patient, wherein the (i) administrated amount is 50% or less of the comparative free drug amount, or (ii) the dosing is once a day or less, or (iii) both.
Claims
exact text as granted — not AI-modified1 . A method of treating or ameliorating pulmonary infection in a cystic fibrosis patient comprising pulmonary administration of an effective amount of a liposomal/complexed antiinfective to the patient, wherein the (i) administrated amount is 50% or less of the comparative free drug amount, or (ii) the dosing is once a day or less, or (iii) both.
2 .- 25 . (canceled)Join the waitlist — get patent alerts
Track US2022016150A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.